4.6 Article

Characterizing the landscape and impact of infections following kidney transplantation

期刊

AMERICAN JOURNAL OF TRANSPLANTATION
卷 21, 期 1, 页码 198-207

出版社

WILEY
DOI: 10.1111/ajt.16106

关键词

-

资金

  1. National Institute of Diabetes and Digestive and Kidney Diseases [F32DK113719, F32DK117563, K01DK101677, K23DK115908, K24DK101828]
  2. Doris Duke Charitable Foundation
  3. American Society of Nephrology

向作者/读者索取更多资源

Infections post-kidney transplantation are common and significantly impact mortality and death-censored graft failure (DCGF), even in the modern era. Kidney transplant recipients at high risk for infections may benefit from enhanced surveillance or follow-up to mitigate these risks.
Infections remain a major threat to successful kidney transplantation (KT). To characterize the landscape and impact of post-KT infections in the modern era, we used United States Renal Data System (USRDS) data linked to the Scientific Registry of Transplant Recipients (SRTR) to study 141 661 Medicare-primary kidney transplant recipients from January 1, 1999 to December 31, 2014. Infection diagnoses were ascertained by International Classification of Diseases, Ninth Revision (ICD-9) codes. The cumulative incidence of a post-KT infection was 36.9% at 3 months, 53.7% at 1 year, and 78.0% at 5 years. The most common infections were urinary tract infection (UTI; 46.8%) and pneumonia (28.2%). Five-year mortality for kidney transplant recipients who developed an infection was 24.9% vs 7.9% for those who did not, and 5-year death-censored graft failure (DCGF) was 20.6% vs 10.1% (P < .001). This translated to a 2.22-fold higher mortality risk (adjusted hazard ratio [aHR]:(2.15)2.22(2.29),P < .001) and 1.92-fold higher DCGF risk (aHR:(1.84)1.91(1.98),P < .001) for kidney transplant recipients who developed an infection, although the magnitude of this higher risk varied across infection types (for example, 3.11-fold higher mortality risk for sepsis vs 1.62-fold for a UTI). Post-KT infections are common and substantially impact mortality and DCGF, even in the modern era. Kidney transplant recipients at high risk for infections might benefit from enhanced surveillance or follow-up to mitigate these risks.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Surgery

Rethinking incompatibility in kidney transplantation

Kyle R. Jackson, Dorry L. Segev

Summary: Donor/recipient incompatibility in kidney transplantation traditionally focused on ABO/HLA incompatibility. However, it is now recognized that factors such as age, weight, and HLA antigens can also impact recipient outcomes. A new paradigm of incompatibility has been proposed to consider all of these risk factors and improve donor/recipient compatibility through KPD.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Transplantation

Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age

JiYoon B. Ahn, Sunjae Bae, Mark Schnitzler, Gregory P. Hess, Krista L. Lentine, Dorry L. Segev, Mara A. McAdams-DeMarco

Summary: The study found that early steroid withdrawal was associated with a decreased risk of posttransplant diabetes (PTD) in kidney transplant recipients. This association was more pronounced in recipients aged 55 and older.

TRANSPLANTATION DIRECT (2022)

Article Surgery

mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients

Sunjae Bae, Jennifer L. Alejo, Teresa P. Y. Chiang, William A. Werbel, Aaron A. R. Tobian, Linda W. Moore, Ashrith Guha, Howard J. Huang, Richard J. Knight, A. Osama Gaber, R. Mark Ghobrial, Mara A. McAdams-DeMarco, Dorry L. Segev

Summary: The study analyzed the impact of COVID-19 vaccination on the immune response of transplant patients, finding that mTOR inhibitors may have an effect on vaccine responses. However, the results indicated that the likelihood of antibody response was higher in patients using both MMF and mTORi, but this protective tendency disappeared after adjusting for MMF.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Surgery

Delirium, changes in cognitive function, and risk of diagnosed dementia after kidney transplantation

Nadia M. Chu, Sunjae Bae, Xiaomeng Chen, Jessica Ruck, Alden L. Gross, Marilyn Albert, Karin J. Neufeld, Dorry L. Segev, Mara A. McAdams-DeMarco

Summary: Kidney transplant recipients with post-transplant delirium may experience worse executive function and increased risk of dementia. However, there may not be significant changes in overall cognitive function in the short term after kidney transplant.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Association between Abdominal CT Measurements of Body Composition before Deceased Donor Liver Transplant with Posttransplant Outcomes

Omid Shafaat, Yi Liu, Kyle R. Jackson, Jennifer D. Motter, Brian J. Boyarsky, Muhammad A. Latif, Frank Yuan, Adham Khalil, Elizabeth A. King, Atif Zaheer, Ronald M. Summers, Dorry L. Segev, Mara McAdams-DeMarco, Clifford R. Weiss

Summary: This study aimed to quantify the association between abdominal CT-based body composition measurements and post-liver transplant mortality. The results showed that pre-liver transplant sarcopenia was significantly associated with post-transplant mortality.

RADIOLOGY (2023)

Article Gastroenterology & Hepatology

Digital imaging software versus the eyeball method in quantifying steatosis in a liver biopsy

Jane J. Long, Kieranjeet Nijhar, Reed T. Jenkins, Adham Yassine, Jennifer D. Motter, Kyle R. Jackson, Stephanie Jerman, Sepideh Besharati, Robert A. Anders, Ty B. Dunn, Christopher L. Marsh, Divya Rayapati, David D. Lee, Rolf N. Barth, Kenneth J. Woodside, Benjamin Philosophe

Summary: Digital imaging software (DIS) can standardize the definition and measurement of macrovesicular steatosis (MaS) and identify phenotypes associated with good clinical outcomes. It provides reproducible quantification of steatosis, which can increase the utilization of steatotic livers.

LIVER TRANSPLANTATION (2023)

Letter Surgery

Impact of expanding HOPE Act experience criteria on program eligibility for transplantation from donors with human immunodeficiency virus to recipients with human immunodeficiency virus

Mary G. Bowring, Jessica M. Ruck, Mitchell G. Bryski, William Werbel, Aaron A. R. Tobian, Allan B. Massie, Dorry L. Segev, Christine M. Durand

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Urology & Nephrology

Incidence of Statin-Associated Adverse Events in Kidney Transplant Recipients

Sunjae Bae, JiYoon B. Ahn, Corey Joseph, Ryan Whisler, Mark A. Schnitzler, Krista L. Lentine, Bernard S. Kadosh, Dorry L. Segev, Mara A. McAdams-DeMarco

Summary: Statins appear to be well tolerated in kidney transplant recipients, but their use may be associated with a slightly higher risk of post-transplant diabetes mellitus, cataract, and rhabdomyolysis.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Urology & Nephrology

Statins in Kidney Transplant Recipients: Usage, All-Cause Mortality, and Interactions with Maintenance Immunosuppressive Agents

Sunjae Bae, JiYoon B. Ahn, Corey Joseph, Ryan Whisler, Mark A. Schnitzler, Krista L. Lentine, Bernard S. Kadosh, Dorry L. Segev, Mara A. McAdams-DeMarco

Summary: This study analyzed a national cohort to assess the real-world effectiveness of statins in reducing all-cause mortality in kidney transplant recipients. The study found that statin use was significantly associated with lower mortality, and this protective effect might be greater when combined with mTOR inhibitors.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Pediatrics

Trajectories of eGFR after kidney transplantation according to trajectories of eGFR prior to kidney replacement therapies in children with chronic kidney disease

Sunjae J. Bae, George J. Schwartz, Susan R. Mendley, Bradley A. Warady, Susan L. Furth, Alvaro Munoz

Summary: This study analyzed eGFR trajectories in pediatric kidney transplant recipients before and after kidney replacement therapy (KRT), and found that risk factors associated with chronic kidney disease (CKD) progression had no significant impact on post-transplant eGFR decline, except for albuminuria and high blood pressure.

PEDIATRIC NEPHROLOGY (2023)

Article Immunology

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics

Nitipong Permpalung, Teresa Po-Yu Chiang, Robin K. Avery, Darin Ostrander, Kausik Datta, Dorry L. Segev, Christine M. Durand, Sean X. Zhang, Allan B. Massie, Kieren A. Marr

Summary: A retrospective study was conducted to investigate COVID-19-associated pulmonary aspergillosis (CAPA), which is likely underdiagnosed and lacks sensitive diagnostic tools. A CAPA prediction model was built using multivariable logistic regression analysis, and the performance of the model was assessed using the area under the receiver operating characteristic curve (AUC). The model identified several factors, such as age, intubation time, dexamethasone treatment, and underlying diseases, that were significantly associated with CAPA, resulting in an AUC of 0.75. Screening at a cutoff of =0.085, the model showed a sensitivity of 82%, specificity of 51%, positive predictive value of 18.6%, and negative predictive value of 95.3%.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Cardiac & Cardiovascular Systems

Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year

Nitipong Permpalung, Tao Liang, Shilpa Gopinath, Katrina Bazemore, Joby Mathew, Darin Ostrander, Christine M. Durand, Shmuel Shoham, Sean X. Zhang, Kieren A. Marr, Robin K. Avery, Pali D. Shah

Summary: This study found that respiratory viral infections are associated with chronic lung allograft dysfunction and mortality in lung transplant recipients. Secondary invasive fungal infections were also found to be prevalent in these patients and were associated with CLAD progression/death. Screening for fungal infections is crucial in this setting.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Letter Medicine, General & Internal

Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial

Niraj M. Desai, Sherry G. Leung, Jennifer D. Motter, Dorry L. Segev, Daniel Warren, Christine M. Durand

ANNALS OF INTERNAL MEDICINE (2023)

Meeting Abstract Immunology

Early Clinical Complications Following HLA-Incompatible Living Donor Kidney Transplantation

Jennifer Motter, Kyle R. Jackson, Allan B. Massie, Jacqueline M. Garonzik-Wang, Dorry L. Segev

TRANSPLANTATION (2022)

暂无数据